Pulike Biological Engineering, Inc. (SHA:603566)
10.45
-0.10 (-0.95%)
Sep 2, 2026, 1:19 PM CST
SHA:603566 Market Cap
SHA:603566 has a market cap or net worth of 3.61 billion as of September 1, 2026. Its market cap has decreased by -28.62% in one year.
Market Cap
3.61B
Enterprise Value
3.02B
Revenue
1.02B
Ranking
n/a
PE Ratio
24.53
Stock Price
10.45
ChartMarket Cap Chart
Since May 18, 2015, SHA:603566's market cap has increased from 3.58B to 3.61B, an increase of 0.87%. That is a compound annual growth rate of 0.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 3.57B | -16.09% |
| Dec 31, 2025 | 4.25B | -2.59% |
| Dec 31, 2024 | 4.36B | -44.34% |
| Dec 29, 2023 | 7.84B | -17.21% |
| Dec 30, 2022 | 9.47B | 36.16% |
| Dec 31, 2021 | 6.95B | 6.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Sihuan Bioengineering | 3.99B |
| Beijing Scitop Bio-tech | 3.87B |
| Shanghai Serum Bio-Technology | 3.75B |
| Assure Tech (Hangzhou) | 3.75B |
| Jiangsu Bioperfectus Technologies | 3.52B |
| Lifecome Biochemistry | 3.41B |
| Shanghai Shen Lian Biomedical | 3.36B |
| Hinova Pharmaceuticals | 3.35B |